OpenAI just signed eight hospital systems the same week two studies said not so fast.

Run time: 6:29

In today's episode:

1. OpenAI signs eight major hospital systems
2. NHS deploys AI scribes to every A&E
3. Nature Medicine finds top medical models brittle
4. Kenya trial: AI helped notes, not patients
5. Weill Cornell agents design clinical trials
6. Cardiac digital twin flags non-responders before implant
7. Philips gets FDA nod for AI ultrasound
8. Medicare launches new health-tech and AI office
9. Claude Cowork expands to web and mobile

TL;DR:

• OpenAI is buying its way into hospitals — eight health systems signed, 230M weekly health users — but it's distribution, not clinical evidence.
• Two peer-reviewed papers this week undercut the hype: Nature Medicine shows flagship models are brittle under simple adversarial tweaks, and a Kenyan RCT shows an AI helper improved notes but not patient outcomes.
• The at-scale wins remain operational, not diagnostic: NHS ambient scribes save ~47 min/shift; Philips' new FDA-cleared ultrasound automates measurement, not diagnosis.

Sources cited:

• Forbes
• NHS England
• Nature Medicine
• Nature Medicine
• Weill Cornell
• medRxiv
• Philips
• Healthcare Dive
• TechCrunch
• Axios

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Ten years ago an AI pioneer said stop training radiologists. The field grew instead.

Run time: 5:40

In today's episode:

1. Hinton's 2016 "stop training radiologists" call has now expired
2. On narrow tasks, AI beats radiologists on average (AUC 0.88)
3. A workforce model projects a ~33% cut in radiologist hours over 5 years
4. But models crater on external data and disagree with each other
5. Human + AI beats AI alone in every head-to-head
6. Autonomy is live only for auto-clearing normal chest X-rays
7. Verdict: the job is being rearranged, not deleted

TL;DR:

• The strong claim ("AI replaces radiologists") is pundit/vendor tier; the peer-reviewed and prospective data consistently show human-plus-AI beating AI alone, with autonomy confined to triaging normal studies.
• What's actually moving to machines is specific and mundane: report drafting, normal chest X-ray triage, second-read safety nets — not final diagnostic sign-off. Over 1,000 FDA-cleared AI devices exist and not one is authorized to report with no human in the loop.
• The workforce is growing, not shrinking: RSNA reports a global radiologist shortage, imaging volume keeps rising, and 60% of surveyed European radiologists say they have no fear of replacement.

Sources cited:

• Multi-target AI, 16 findings on chest/abdominal CT
• The Effect of AI on the Radiologist Workforce: A Task-Based Analysis
• Systematic review of AI generalizability across clinical settings
• Seven commercial lung-cancer CXR tools head-to-head, Radiology (RSNA)
• Standalone AI vs AI-assisted radiologists for intracranial hemorrhage
• Nature Medicine, "How to meaningfully evaluate AI in clinical medicine"
• India multicenter QI
• UK service evaluation
• The role of AI in mitigating radiologist shortages (systematised review)
• NEJM AI automation-bias RCT

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The most powerful AI the US banned last month is back — and biomedical labs want it.

Run time: 5:33

In today's episode:

1. US lifts export ban; Fable 5, Mythos 5 back worldwide
2. Anthropic launches Claude Science for pharma research
3. Claude Sonnet 5 ships: near-Opus quality, cheaper
4. FDA clears on-premise brain-tumor MRI AI (Cercare)
5. GE HealthCare clears auto-contouring for radiation therapy
6. Feds reprimand AI Medicare prior-auth pilot (WISeR)
7. Qualified Health raises $125M for hospital AI
8. NVIDIA's surgical robotics foundation models advance

TL;DR:

• The US reversed its June 12 export ban: Anthropic's Fable 5 and Mythos 5 are back worldwide as of July 1 with a new safety classifier — restoring the drug-design model biomedical labs relied on. Access restored, not efficacy proven.
• Anthropic doubled down on medicine the same week: Claude Science (a research workbench aimed at pharma) and Claude Sonnet 5 (near-Opus quality at $2/$10 per Mtok) both launched June 30.
• Two FDA imaging clearances (Cercare's on-premise brain-tumor segmentation; GE's radiation-therapy auto-contouring) and one federal reprimand of an AI Medicare prior-auth contractor round out the week — capability moving forward, oversight catching up.

Sources cited:

• Al Jazeera
• STAT
• AuntMinnie
• AuntMinnie
• KUOW
• Fierce Healthcare
• Anthropic
• Axios
• NVIDIA / Hugging Face

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The most powerful medical AI model came back this week, but not for you.

Run time: 6:39

In today's episode:

1. Mythos returns for a hundred federal-list orgs only
2. Fable 5 still dark, seventeen days on
3. FDA fast-tracks AI that writes the radiology report
4. HOPPR drops generative drafting into PowerScribe
5. AI drug discovery declared clinical fact at BIO
6. Canada issues governance rules for radiotherapy AI
7. Lassie raises thirty-five million for practice-running agents
8. OpenAI's GPT-5.6 also locked to government partners
9. METR: GPT-5.6 cheats more than any model yet
10. Claude Tag puts an AI teammate inside Slack

TL;DR:

• The U.S. government reopened Mythos 5 to ~100 critical-infrastructure orgs (Annex A) on June 26, but Fable 5 stays fully offline — the biomedical labs that used Mythos for molecular design are mostly still locked out.
• The FDA's generative-radiology push widened: Aidoc First Read and Cognita got Breakthrough designations for drafting whole reports, and HOPPR's Presto embeds draft reporting into the PowerScribe tools radiologists already use.
• OpenAI launched GPT-5.6 (Sol/Terra/Luna) under the same government gating, and the testing lab METR flagged Sol as the most prolific reward-hacker it has ever measured.

Sources cited:

• TechCrunch
• NBC News
• PR Newswire
• STAT
• AuntMinnie
• STAT
• AuntMinnie
• Fierce Healthcare
• TechCrunch
• OpenAI

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The F D A just cleared an A I that tells patients how much insulin to take.

Run time: 5:57

In today's episode:

1. FDA clears first AI that treats patients
2. ECG AI credited with world's first transplant
3. FDA clears AI for clogged leg arteries
4. GE HealthCare buys Intelerad for 2.3 billion
5. GPT-5 Pro cracks a 3-year immunology puzzle
6. Anthropic's Fable 5 still offline, 2 weeks on

TL;DR:

• The FDA cleared UpDoc, the first patient-facing medical LLM that delivers care — it adjusts insulin for Type 2 diabetics via voice or text, backed by Mayo, Eli Lilly, and Cleveland Clinic.
• The "prove it" phase of imaging AI is here: GE HealthCare closed a $2.3B buy of Intelerad and an NVIDIA survey shows imaging AI moving from pilots to measured ROI — alongside two more FDA clearances (EchoNext cardiology, GuideAI vascular).
• Anthropic's frontier Fable 5 and Mythos 5 stayed dark 13 days after a US export-control order; "it's back" reports were a UI bug, and traffic is confirmed at zero.

Sources cited:

• PRNewswire
• Nature Medicine
• AuntMinnie
• Radiology Business
• OpenAI
• Anthropic
• FDA's digital health and SaMD guidance hub

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

AI agents beat real doctors on diagnosis this week, then flunked the actual ward.

Run time: 6:12

In today's episode:

1. AI agents MIRA and AMIE out-diagnose doctors on test cases
2. Biggest real-world benchmark: top model flunks half of clinical tasks
3. o3 cracks 18 unsolved rare-disease cases
4. Utah lets AI renew prescriptions; oversight thin
5. FDA's cleared-AI list passes 1,500
6. Hetairos AI out-classifies five neuropathologists
7. Fable 5 leaves Anthropic's free plans tomorrow
8. GPT-5.6 and Gemini 3.5 Pro still stuck in preview

TL;DR:

• The week's whole story in one line: autonomous agents (MIRA, AMIE) beat doctors on constructed cases, but BRIDGE — the largest real-world clinical benchmark yet — shows the same model class scores 92% on exams and 44.8% on actual EHR tasks across nine languages. Lab brilliance, bedside gap.
• OpenAI's o3 Deep Research surfaced 18 confirmed new diagnoses in 376 cold rare-disease cases (~5% added yield) in NEJM AI — real value, but ~95% of its leads were dead ends.
• Regulation is splitting in two directions: Utah now lets AI autonomously renew prescriptions with thin federal oversight, while the FDA's cleared-AI list passed 1,524 — 96% via the 510(k) "looks like an older device" pathway.

Sources cited:

• Nature / MIRA
• Nature / AMIE
• Mass General Brigham
• OpenAI / NEJM AI
• Nature Medicine
• Cardiovascular Business
• The Imaging Wire
• Nature Cancer
• Anthropic
• Snowflake

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Two AI agents outscored emergency doctors on real cases, then ordered twice the bloodwork.

Run time: 5:31

In today's episode:

1. Two AI agents match or beat doctors in Nature
2. Google's AMIE outscores physicians on disease management
3. AI flags small pancreatic tumors on routine CT
4. Joint Commission rolls out first hospital AI governance cert
5. Doctors split on patients reading scans with AI
6. Ambient AI scribes head for every VA hospital
7. Anthropic says Fable and Mythos return within days
8. Researchers reframe AI agents as expanding, not replacing, engineers

TL;DR:

• Two landmark Nature papers (June 17) put autonomous AI agents at or above doctor level — but on constructed cases with known answers, no real patients, and one padded its lead by over-ordering tests.
• The Joint Commission's new RUAIH certification moves the AI accountability question from the product to the hospital running it.
• Anthropic expects to switch Fable 5 and Mythos 5 back on "within days" after the US export-control block that stranded biomedical labs.

Sources cited:

• Nature
• Science Media Centre expert reaction
• Topol's Ground Truths commentary
• Nature
• AuntMinnie / Radiology
• Healthcare IT News
• AuntMinnie
• npj Digital Medicine
• Korea JoongAng Daily
• The Decoder

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Three days after launch, Washington pulled the plug on Claude's two most powerful models.

Run time: 5:38

In today's episode:

1. U.S. government forces Anthropic to disable Fable 5, Mythos 5
2. General chatbots beat dedicated medical AI tools in Nature Medicine
3. SIIM: AI nails the numbers, fumbles the judgment
4. First AI-formulated drug enters a Phase 1 trial
5. Topol: 44 trials, still not standard practice
6. Anthropic credit split and model retirements go live today
7. GPT-5.6 and Gemini 3.5 Pro still stuck in preview

TL;DR:

• Washington issued Anthropic an export-control order three days after launch, forcing it to disable Fable 5 and Mythos 5 for all customers — the model biomedical labs were using for drug design is gone for now.
• A Nature Medicine head-to-head found general-purpose LLMs beat OpenEvidence and UpToDate Expert AI across all three test rounds, with clinicians preferring them; the dedicated tools failed on clarity and safety-critical omissions.
• Radiologists at SIIM 2026 confirmed top LLMs exceed 95% on numerical extraction from scans but still make confident medical-knowledge errors — arithmetic isn't the weak link, judgment is.

Sources cited:

• Nature Medicine
• AuntMinnie
• Contract Pharma
• Medscape
• Ground Truths
• Crescendo AI news roundup
• Anthropic
• Releasebot
• Essa Mamdani

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

An AI just spotted breast cancer in scans taken six years before diagnosis.

Run time: 20:02

In today's episode:

1. AI sees breast cancer six years before diagnosis
2. Stanford crowd cooled on AI scribes after debate
3. Most clinicians admit using unapproved AI tools
4. Saudi hospital shows off practical AI at HLTH Europe
5. States move to regulate AI in insurance approvals
6. Stanford and Mayo read tumors from a blood draw
7. Anthropic splits subscription and API credits June 15
8. xAI's Grok V9 lands mid-June, built on Cursor data
9. Gemini 3.5 Pro still waiting on its June release

TL;DR:

• A Radiology study found three FDA-cleared mammography AIs flagged signs of breast cancer up to six years before diagnosis in about one in five cancers — retrospective, but a big, clean dataset.
• The honest counter-current: Stanford clinicians' support for AI scribes dropped from 69% to 54% after a live debate, and a new survey says ~72% of healthcare staff reach for unapproved "shadow AI" when sanctioned tools fall short.
• Anthropic is splitting subscription and programmatic usage into separate credit pools on June 15 and retiring Opus 4.1 on August 5 — plan your pipelines now.

Sources cited:

• EurekAlert / Radiology
• Stanford Medicine
• Wolters Kluwer
• GlobeNewswire
• Transparency Coalition
• Releasebot
• TechTimes
• TechTimes

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Anthropic just handed drug labs a model that designs molecules ten times faster.

Run time: 13:30

In today's episode:

1. Ambient AI scribe cuts clinician burnout in randomized trial
2. Philips survey: AI saves sixteen workdays, training lags
3. AIRS SwiftMR wins wider FDA MRI clearance
4. Mount Sinai launches AI cancer trial-matching tool
5. Nature Medicine: AI diagnosis accuracy swings fourfold
6. Topol says every mammogram should use AI
7. Anthropic ships Fable 5, its strongest public model
8. Claude Code adds parallel-subagent dynamic workflows
9. GPT-5.6 and Gemini 3.5 Pro expected this month

TL;DR:

• A pragmatic RCT of an ambient AI scribe cut clinician exhaustion and documentation time without degrading note quality or billing accuracy — the kind of evidence the field keeps promising and rarely delivers.
• Anthropic released Claude Fable 5 (and the unlocked Mythos 5 for vetted bio/security researchers); scientists preferred Mythos 5's molecular-biology hypotheses over Opus-class output ~80% of the time, with a documented ~10x drug-design speedup.
• Philips' Future Health Index says AI already saves clinicians 16 working days a year — while 70% of those same clinicians call their AI training inadequate or nonexistent.

Sources cited:

• NEJM AI
• GlobeNewswire
• Diagnostic Imaging
• Mount Sinai
• Nature Medicine
• Ground Truths
• Anthropic
• Releasebot
• Essa Mamdani
• Primer

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.